
Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …

Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia

